Keratinocyte IL-17RA signaling promotes neutrophil recruitment and clinical lesions in experimental epidermolysis bullosa

Epidermolysis bullosa acquisita (EBA) is an autoimmune blistering disease (AIBD) characterized by anti-type VII collagen autoantibody-mediated tissue injury. Neutrophils have been identified as essential for dermal-epidermal separation in various in vitro and mouse models of EBA. Although interleukin-17 (IL-17) signaling promotes neutrophilic inflammation, its contribution to EBA and the relevant responding cell types remain poorly defined. We investigated the role and cellular targets of IL-17 receptor A (IL-17RA) signaling using an antibody-transfer model of EBA in mice with global IL-17RA deficiency, combined IL-17A/IL-17F deficiency, IL-17F deficiency, or myeloid cell- or keratinocyte-specific IL-17RA deletion. Complementary in vitro assays assessed IL-17A-induced chemokine expression and neutrophil migration. Global IL-17RA deficiency, combined IL-17A/IL-17F deficiency, and IL-17F deficiency significantly reduced disease severity in vivo. Keratinocyte-specific IL-17RA deletion markedly attenuated EBA, whereas myeloid cell-specific deletion did not confer protection. In vitro, IL-17A increased Cxcl1 mRNA expression in keratinocytes and fibroblasts, and conditioned media from stimulated cells promoted neutrophil migration. These findings identify keratinocytes as key cellular targets of IL-17RA signaling in experimental EBA and support a mechanism linking epithelial cytokine responses to neutrophil recruitment and tissue injury. Our data support investigating the keratinocyte IL-17RA pathway as a potential therapeutic target in EBA and related AIBD.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-19
DOI
https://doi.org/10.64898/2026.11.18.767503
Primary Topic
Skin and Cellular Biology Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Keratinocyte IL-17RA signaling promotes neutrophil recruitment and clinical lesions in experimental epidermolysis bullosa

Fengyuan Deng, Ralf Joachim Ludwig, Immo Prinz, Ari Waisman et al.
bioRxiv (Cold Spring Harbor Laboratory)
Skin and Cellular Biology Research
preprint

Keratinocyte IL-17RA signaling promotes neutrophil recruitment and clinical lesions in experimental epidermolysis bullosa

Fengyuan Deng, Ralf Joachim Ludwig, Immo Prinz, Ari Waisman, Burkhard Becher, Enno Schmidt, Christoph Hölscher, Xinhua Yu, Frank Petersen, Sandra Jukić, Alexandra Hölscher
preprint en

Abstract

Epidermolysis bullosa acquisita (EBA) is an autoimmune blistering disease (AIBD) characterized by anti-type VII collagen autoantibody-mediated tissue injury. Neutrophils have been identified as essential for dermal-epidermal separation in various in vitro and mouse models of EBA. Although interleukin-17 (IL-17) signaling promotes neutrophilic inflammation, its contribution to EBA and the relevant responding cell types remain poorly defined. We investigated the role and cellular targets of IL-17 receptor A (IL-17RA) signaling using an antibody-transfer model of EBA in mice with global IL-17RA deficiency, combined IL-17A/IL-17F deficiency, IL-17F deficiency, or myeloid cell- or keratinocyte-specific IL-17RA deletion. Complementary in vitro assays assessed IL-17A-induced chemokine expression and neutrophil migration. Global IL-17RA deficiency, combined IL-17A/IL-17F deficiency, and IL-17F deficiency significantly reduced disease severity in vivo. Keratinocyte-specific IL-17RA deletion markedly attenuated EBA, whereas myeloid cell-specific deletion did not confer protection. In vitro, IL-17A increased Cxcl1 mRNA expression in keratinocytes and fibroblasts, and conditioned media from stimulated cells promoted neutrophil migration. These findings identify keratinocytes as key cellular targets of IL-17RA signaling in experimental EBA and support a mechanism linking epithelial cytokine responses to neutrophil recruitment and tissue injury. Our data support investigating the keratinocyte IL-17RA pathway as a potential therapeutic target in EBA and related AIBD.

bioRxiv (Cold Spring Harbor Laboratory)
Universität Hamburg (DE), Johannes Gutenberg University Mainz (DE), University of Zurich (CH), University Medical Center of the Johannes Gutenberg University Mainz (DE), University Medical Center Hamburg-Eppendorf (DE), Research Center Borstel - Leibniz Lung Center (DE), University of Lübeck (DE)
Skin and Cellular Biology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon